XML 29 R17.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Stock Options | 12 Months Ended
--- | ---
Dec. 31, 2017
Stock Options [Abstract] |
STOCK OPTIONS | NOTE 11 – STOCK OPTIONS The Company sponsors a stock-based incentive compensation plan known as the 2013 Equity Compensation Plan (the “Plan”), which was established by the Board of Directors of the Company in June 2013. A total of 1,500,000 shares were initially reserved for issuance under the Plan. The Plan was amended in 2016 to increase the authorized shares to 4,000,000 shares and again in 2018 to increase the authorized shares to 5,500,000. A total of 4,106,250 options were outstanding at December 31, 2016. In addition, a total of 735,105 restricted shares were granted in 2014 and 2015, but not issued at the time. A total 685,015 of these shares were redeemed for cash in 2016, and 50,000 of these shares were issued in 2016. As of December 31, 2017, the Company has no remaining restricted shares owed. The Company had no remaining shares available to grant under the Plan at December 31, 2017. The Plan allows the Company to grant incentive stock options, non-qualified stock options, stock appreciation right, or restricted stock. The incentive stock options are exercisable for up to ten years, at an option price per share not less than the fair market value on the date the option is granted. The incentive stock options are limited to persons who are regular full-time employees of the Company at the date of the grant of the option. Non-qualified options may be granted to any person, including, but not limited to, employees, independent agents, consultants and attorneys, who the Company’s Board or Compensation Committee believes have contributed, or will contribute, to the success of the Company. Non-qualified options may be issued at option prices of less than fair market value on the date of grant and may be exercisable for up to ten years from date of grant. The option vesting schedule for options granted is determined by the Compensation Committee of the Board of Directors at the time of the grant. The Plan provides for accelerated vesting of unvested options if there is a change in control, as defined in the Plan. Prior to establishment of the Plan, the Board granted options under terms similar to those described in the preceding paragraphs. A total of 25,000 options were outstanding at December 31, 2016 that were granted prior to the establishment of the 2013 Plan, but those options expired in 2017. The compensation cost that has been charged against income related to options for the years ended December 31, 2017 and 2016, was $815,014 and $384,126, respectively. No income tax benefit was recognized in the income statement and no compensation was capitalized in any of the years presented. The Company had the following option activity during the years ended December 31, 2017 and 2016:
|  | Number of Options |  |  | Weighted average exercise price |  |  | Weighted average remaining contractual life (years) |  |  | Aggregate intrinsic value $ |
Outstanding, January 1, 2016 |  |  | 1,615,000 |  |  | $ | 1.09 |  |  |  |  |  |  |  |  |
Granted - 2016 |  |  | 2,040,000 |  |  | $ | 1.09 |  |  |  |  |  |  |  |  |
Exercised - 2016 |  |  | (485,000 | ) |  | $ | 0.89 |  |  |  |  |  |  |  |  |
Expired – 2016 |  |  | (50,000 | ) |  | $ | 1.08 |  |  |  |  |  |  |  |  |
Outstanding, December 31, 2016 |  |  | 3,120,000 |  |  | $ | 1.12 |  |  |  | 3.6 |  |  |  |  |
Granted – 2017 |  |  | 1,441,250 |  |  | $ | 0.96 |  |  |  |  |  |  |  |  |
Exercised – 2017 |  |  | (130,000 | ) |  | $ | 1.27 |  |  |  |  |  |  |  |  |
Expired – 2017 |  |  | (325,000 | ) |  | $ | 1.34 |  |  |  |  |  |  |  |  |
Outstanding, December 31, 2017 |  |  | 4,106,250 |  |  | $ | 1.04 |  |  |  | 3.2 |  |  | $ | 2,173,700 |
Exercisable, December 31, 2017 |  |  | 1,891,250 |  |  | $ | 1.02 |  |  |  | 2.9 |  |  | $ | 1,035,900 |
Of the options outstanding at December 31, 2016, 1,220,000 were exercisable with a weighted average contractual life of 1.1 years and the remaining 1,900,000 were non-vested. The table below shows the expiration date and exercise price of the options outstanding at December 31, 2017.
Number of Options |  | Exercise Price |  | Expiration Date
600,000 |  | $0.82 |  | 03/31/22
150,000 |  | $1.00 |  | 10/30/18
1,135,000 |  | $1.05 |  | 03/03/19
1,500,000 |  | $1.07 |  | 02/22/21
500,000 |  | $1.15 |  | 07/28/21
20,000 |  | $1.17 |  | 11/01/22
100,000 |  | $1.22 |  | 03/03/19
31,250 |  | $1.57 |  | 12/31/22
10,000 |  | $1.85 |  | 01/29/19

X
- Definition The entire disclosure for compensation-related costs for equity-based compensation, which may include disclosure of policies, compensation plan details, allocation of equity compensation, incentive distributions, equity-based arrangements to obtain goods and services, deferred compensation arrangements, employee stock ownership plan details and employee stock purchase plan details. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 50 -URI http://asc.fasb.org/subtopic&trid=2208855 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration